# Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects

> **NCT02780375** · — · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 20 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Blood donation during radiotherapy

## Key facts

- **NCT ID:** NCT02780375
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-12
- **Primary completion:** 2018-07-17
- **Final completion:** 2018-07-17
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780375, "Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02780375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*